NCT00577161 2020-10-05Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHLCTI BioPharmaPhase 3 Withdrawn
NCT02800889 2020-01-29Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory CancerCTI BioPharmaPhase 1 Withdrawn